Scientific reports · 2025
70% ethanol preserves mycobacterial RNA from cultures more efficiently than GTC-TCEP.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Krausser Lena, Van Dyck-Lippens Magalie, Balde Ramata, Reenaers Rabab, Al Mubarak Reem, Rigouts Leen, Walter Nicholas D, Voskuil Martin I, Van Rie Annelies, de Jong Bouke C, Braet Sofie M
Аннотация
RNA-based assays hold great potential for assessing viability molecularly in slow- or non-growing mycobacteria, and RNAseq has evolved into a powerful tool in infectious disease research. Such applications require efficient RNA preservation for optimal results. The performance of 70% ethanol as simpler alternative to commonly-used GTC-based storage of mycobacteria at - 80 °C was compared on cultured Mycobacterium tuberculosis H37Ra subjected to following setups: a 45 °C heat shock to test immediate stabilisation, five freeze-thaw scenarios to mimic different shipping conditions, and long-term storage at -80 °C, -20 °C, 4 °C or 30 °C for up to twelve months. Treatment with 70% ethanol yielded overall higher RNA quantities compared to GTC-TCEP and RNA integrity was maintained at -20 °C for twelve months. Both buffers are reportedly mycobactericidal and, in this study, prevented heat stress-induced transcriptomic changes, thereby conserving a transcriptomic snapshot. RNA yield and integrity remained unaltered after treatment with 70% ethanol, even with up to three freeze-thaw cycles. Based on these results, we recommend 70% ethanol over GTC-TCEP for RNA preservation of mycobacterial cultures. While freeze-thawing, short-term high-temperature and - 20 °C long-term storage results are promising, this inexpensive, widely available buffer needs further validation prior to applying it for RNA-based analysis in clinical samples.